1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Global Cephalosporin Drugs Market: Trend Analysis and Forecast to 2022

Global Cephalosporin Drugs Market: Trend Analysis and Forecast to 2022

  • August 2016
  • 100 pages
  • ID: 4652931

Summary

Table of Contents

Cephalosporins are medicine that kill bacteria or prevent their growth. Cephalosporin drugs are a newer class of antibiotics and often are seen as an alternative to penicillin for many patients. Moreover, clinical studies are ongoing for comparing this class of antibiotics to penicillin in combating various infections. Cephalosporin drugs are used to treat infections in different parts of the body such as ears, nose, throat, lungs, sinuses, and skin. Physicians also prescribe these drugs to treat pneumonia, strep throat, staph infections, tonsillitis, bronchitis, and gonorrhea. Hence multiple benefits associated with cephalosporin drugs are likely to boost the size of global cephalosporin drugs market in the near future.

In 2014, size of the global Cephalosporin drugs market was valued USD XXX million and it is expected to grow with a CAGR of X.X% over the period of 2016 to 2022 and reach USD XXX million by 2022. Rising prevalence of infectious diseases, increasing awareness among patients, multiple treatment options and special regulatory designation for pipeline molecules are considered to be prime factors driving the growth of cephalosporin market. Stringent government policies, low investment in R&D activities and high generic penetration of these drugs are the key restraining factors for the growth of the market. Moreover, use of combination therapies for treatment, development of highly efficient and safe cephalosporin drugs, and increasing incidence of mergers and acquisition are anticipated to bring more opportunities for the growth of this market. Furthermore, resistance by government on drug development and weak pipeline molecules are some of the primary challenges faced by the global Cephalosporin drugs market.

Segments Covered:
The report segments the Cephalosporin drugs market by, generation of cephalosporin and by route of drug administration. The market segmentation based on generation of cephalosporin includes First-generation cephalosporin, Second-generation cephalosporin, Third-generation cephalosporin, Fourth-generation cephalosporin and Fifth-generation cephalosporin. Moreover, the global cephalosporin drugs market is segmented based on route of drug administration into Injection and Oral. The injection segment is accounted for the most preferred route of drug administration as it results in quick drug delivery.

Geographic Coverage and Analysis:
The report provides regional analysis covering geographies such as North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW). Asia pacific is accounted for the largest share of market in the global cephalosporin drugs market. Asia Pacific continued its dominance by covering more than 50% market share between 2014 and 2016. Increasing demand for highly developed healthcare infrastructure, increasing awareness about cephalosporin’s drugs among the patients and benefits associated with it are expected to be the key factors supporting the growth of this region over the forecast period. North America is considered to be the most attractive market by region over the forecast period and anticipated to grow at the highest CAGR due to rising prevalence in infectious diseases in the region.

Companies profiled:
The companies covered in the report include- Allergan, Astellas,
- Bristol-Myers Squibb,
- GSK,
- Merck,
- Abbott,
- Aspen Pharmacare,
- AstraZeneca,
- Johnson & Johnson,
- Sun Pharmaceutical,
- Orchid Pharma,
- Theravance Biopharma,
- Pfizer,
- Baxter,
- Basilea Pharmaceuticals,
- Incepta Pharmacueticals,
- Sandoz and
- others.

Report Highlights:
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of cephalosporin drugs globally as well as regionally. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter’s five forces analysis and value chain analysis of cephalosporin drugs market. Moreover, the study highlights current market trends and provides forecast from 2016 to 2022. We also have highlighted future trends in the cephalosporin drugs market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Veronica helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
2018 Global Clinical Chemistry and Immunodiagnostics Market: US, Europe, Japan--Analyzers and Reagents-- Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

2018 Global Clinical Chemistry and Immunodiagnostics Market: US, Europe, Japan--Analyzers and Reagents-- Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

  • $ 23500
  • Industry report
  • June 2018
  • by Venture Planning Group

The report is a seven-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report explores future ...

Immunodiagnostics: Spot Fast-Growing Market Segments--Therapeutic Drug Monitoring, Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse

Immunodiagnostics: Spot Fast-Growing Market Segments--Therapeutic Drug Monitoring, Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse

  • $ 15900
  • Industry report
  • June 2018
  • by Venture Planning Group

This comprehensive seven-country report contains 1,115 pages and 450 tables. The report explores future trends in the U.S., five major European countries (France, Germany, Italy, Spain, UK) and Japan; ...

2018 Europe Clinical Chemistry and Immunodiagnostics Market: France, Germany, Italy, Spain, UK--Analyzers and Reagents

2018 Europe Clinical Chemistry and Immunodiagnostics Market: France, Germany, Italy, Spain, UK--Analyzers and Reagents

  • $ 12800
  • Industry report
  • June 2018
  • by Venture Planning Group

The report is a five-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report explores future ...

Global Antibiotics Market $ 4250 July 2018


ref:plp2016

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on